Effect of edaravone against consciousness impairment after encephalitis
Phase 2
- Conditions
- imbic encephalitis
- Registration Number
- JPRN-UMIN000010052
- Lead Sponsor
- niversity of Tsukuba
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1.male:Cre<1.3 mg/dl Female:Cre<1.0 mg/dl male & femaile:AST/ALT<more than three times the reference value 2.sepsis 3.epilepticus and severe coma 4.bacterial meningitis and encephalitis 5.DIC 6.allergy for edaravone 7. edaravone is used within two weeks prior to registration 8.acute cereberal infarction 9.Patients within 6 months after the end of the other trial 10.investigator has determined the patient disqualified as a target
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method